ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD
Overview
ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering BUPROPION HYDROCHLORIDE; QUETIAPINE FUMARATE; ß-NICOTINAMIDE ADENINE DINUCLEOTIDE.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- ß-NICOTINAMIDE ADENINE DINUCLEOTIDEActive2026-01-13
- BUPROPION HYDROCHLORIDEActive2025-06-17
- QUETIAPINE FUMARATEActive2024-06-07
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this ZHEJIANG SYNCOZYMES BIO-PHARMACEUTICAL CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.